Search Results - "Harpel, John" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma

by Niesvizky, Ruben, Jayabalan, David S., Christos, Paul J., Furst, Jessica R., Naib, Tara, Ely, Scott, Jalbrzikowski, Jessica, Pearse, Roger N., Zafar, Faiza, Pekle, Karen, LaRow, April, Lent, Richard, Mark, Tomer, Cho, Hearn J., Shore, Tsiporah, Tepler, Jeffrey, Harpel, John, Schuster, Michael W., Mathew, Susan, Leonard, John P., Mazumdar, Madhu, Chen-Kiang, Selina, Coleman, Morton
Published in Blood (01.02.2008)

Get full text

Journal Article

Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

by Schuster, Michael W., Shore, Tsiporah B., Harpel, John G., Greenberg, June, Jalilizeinali, Bita, Possley, Scott, Gerwien, Robert W., Hahne, William, Halvorsen, Yuan-Di C.
Published in Supportive care in cancer (01.05.2008)

Get full text

Journal Article

$Lintuzumab-225Ac in Combination with Venetoclax in Relapsed/Refractory AML: Early Results of a Phase I/II Study$

Lintuzumab-225Ac in Combination with Venetoclax in Relapsed/Refractory AML: Early Results of a Phase I/II Study

by Hegazi, Mohamed M., Harpel, John G., Miao, Sara, Ludwig, Dale, Berger, Mark S., Schiller, Gary J.
Published in Blood (05.11.2020)

Get full text

Journal Article

$AML-253: Trials in Progress: A Phase I/II Study of Venetoclax and Lintuzumab-Ac225 in Patients with Refractory or Relapsed AML$

AML-253: Trials in Progress: A Phase I/II Study of Venetoclax and Lintuzumab-Ac225 in Patients with Refractory or Relapsed AML

by Hegazi, Mohamed, Finn, Laura, Roboz, Gail, Harpel, John, Schiller, Gary
Published in Clinical lymphoma, myeloma and leukemia (01.09.2020)

Get full text

Journal Article

Interactions between Growth Factors and Integrins: Latent Forms of Transforming Growth Factor-β Are Ligands for the Integrin αvβ1

Interactions between Growth Factors and Integrins: Latent Forms of Transforming Growth Factor-β Are Ligands for the Integrin αvβ1

by Munger, John S., Harpel, John G., Giancotti, Filippo G., Rifkin, Daniel B.
Published in Molecular biology of the cell (01.09.1998)

Get full text

Journal Article

Latent transforming growth factor-β: Structural features and mechanisms of activation

Latent transforming growth factor-β: Structural features and mechanisms of activation

by Munger, John S., Harpel, John G., Gleizes, Pierre-Emmanuel, Mazzieri, Roberta, Nunes, Irene, Rifkin, Daniel B.
Published in Kidney international (01.05.1997)

Get full text

Journal Article Conference Proceeding

TGF‐β Latency: Biological Significance and Mechanisms of Activation

TGF‐β Latency: Biological Significance and Mechanisms of Activation

by Gleizes, Pierre‐Emmanuel, Munger, John S., Nunes, Irene, Harpel, John G., Mazzieri, Roberta, Noguera, Irene, Rifkin, Daniel B.
Published in Stem cells (Dayton, Ohio) (01.01.1997)

Get full text

Journal Article

Tamoxifen and Estrogen Effects on TGF-β Formation: Role of Thrombospondin-1, αvβ3, and Integrin-Associated Protein

Tamoxifen and Estrogen Effects on TGF-β Formation: Role of Thrombospondin-1, αvβ3, and Integrin-Associated Protein

by Harpel, John G., Schultz-Cherry, Stacey, Murphy-Ullrich, Joanne E., Rifkin, Daniel B.
Published in Biochemical and biophysical research communications (01.06.2001)

Get full text

Journal Article

Cyclophosphamide Overcomes the Suppressive Effect of LenalidomideTherapy on Stem Cell Collection in Preparation for Autologous Stem Cell Transplantation for Multiple Myeloma

Cyclophosphamide Overcomes the Suppressive Effect of LenalidomideTherapy on Stem Cell Collection in Preparation for Autologous Stem Cell Transplantation for Multiple Myeloma

by Mark, Tomer, Jayabalan, David, Pearse, Roger N., Stern, Jessica, Furst, Jessica, Rambo, April, Harpel, John, Shore, Tsiporah, Schuster, Michael, Leonard, John P., Christos, Paul J., Coleman, Morton, Niesvizky, Ruben
Published in Blood (16.11.2007)

Get full text

Journal Article

Role of the Latent TGF-β Binding Protein in the Activation of Latent TGF-β by Co-Cultures of Endothelial and Smooth Muscle Cells

Role of the Latent TGF-β Binding Protein in the Activation of Latent TGF-β by Co-Cultures of Endothelial and Smooth Muscle Cells

by Flaumenhaft, Robert, Abe, Mayumi, Sato, Yasufumi, Miyazono, Kohei, Harpel, John, Heldin, Carl-Henrik, Rifkin, Daniel B.
Published in The Journal of cell biology (01.02.1993)

Get full text

Journal Article

Breaking the Plateau Response in Myeloma: Preliminary Results of a Phase II Pilot Study of Sequential Bortezomib in Combination with Dexamethasone and Pegylated Liposomal Doxorubicin (DoVeD) in Patients No Longer Responsive to Standard Induction Regimens

Breaking the Plateau Response in Myeloma: Preliminary Results of a Phase II Pilot Study of Sequential Bortezomib in Combination with Dexamethasone and Pegylated Liposomal Doxorubicin (DoVeD) in Patients No Longer Responsive to Standard Induction Regimens

by Di Carlo, Brian A., Stern, Jessica L., Schuster, Michael, Shore, Tsiporah, Harpel, John, Pearse, Roger, Zafar, Faiza, Dymek, Joanne, Ryan, Jessy, Jayabalan, David, Chen-Kiang, Selina, Ely, Scott, Leonard, John P., Coleman, Morton, Niesvizky, Ruben
Published in Blood (16.11.2006)

Get full text

Journal Article

Bortezomib Added to the Standard Mobilization Regimen of G-CSF and High-Dose Cyclophosphamide Is a Safe and Effective Combination for a High Yield Stem Cell Collection While Promoting Further Tumor Mass Reduction in Myeloma

Bortezomib Added to the Standard Mobilization Regimen of G-CSF and High-Dose Cyclophosphamide Is a Safe and Effective Combination for a High Yield Stem Cell Collection While Promoting Further Tumor Mass Reduction in Myeloma

by Stern, Jessica L., Di Carlo, Brian, Schuster, Michael W., Shore, Tsiporah B., Harpel, John G., Pearse, Roger, Zafar, Faiza, Dymek, Joanne, Ryan, Jessy, Jayabalan, David, Chen-Kiang, Selina, Ely, Scott, Leonard, John P., Coleman, Morton, Niesvizky, Ruben
Published in Blood (16.11.2006)

Get full text

Journal Article

Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple Myeloma

Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple Myeloma

by Mark, Tomer, Stern, Jessica, Furst, Jessica R, Jayabalan, David, Zafar, Faiza, LaRow, April, Pearse, Roger N, Harpel, John, Shore, Tsiporah, Schuster, Michael W, Leonard, John P, Christos, Paul J, Coleman, Morton, Niesvizky, Ruben
Published in Biology of blood and marrow transplantation (01.07.2008)

Get full text

Journal Article

$Depsipeptide in the Treatment of Relapsed and Refractory Multiple Myeloma (MM): A Prospective Evaluation of the Cell Cycle$

Depsipeptide in the Treatment of Relapsed and Refractory Multiple Myeloma (MM): A Prospective Evaluation of the Cell Cycle

by Goldberg, Zoe, Ely, Scott, Chen-Kiang, Selina, Chesi, Martha, Bergsagel, Peter L., Pekle, Karen, Lyons, Larry, Gelbshtein, Udi, Pearse, Roger, Harpel, John, Cho, Hearn, Coleman, Morton, Niesvizky, Ruben
Published in Blood (16.11.2004)

Get full text

Journal Article

TGF-beta: structure, function, and formation

TGF-beta: structure, function, and formation

by Rifkin, D B, Kojima, S, Abe, M, Harpel, J G
Published in Thrombosis and haemostasis (01.07.1993)

Get more information

Journal Article

Role of the latent TGF-(beta) binding protein in the activation of latent TGF-(beta) by co-cultures of endothelial and smooth muscle cells

Role of the latent TGF-(beta) binding protein in the activation of latent TGF-(beta) by co-cultures of endothelial and smooth muscle cells

by Flaumenhaft, Robert, Harpel, John, Heldin, Carl-Henrik, Rifkin, Daniel B
Published in The Journal of cell biology (01.02.1993)

Get full text

Journal Article

A Study of a Reduced-Intensity Conditioning Regimen Followed by Allogeneic Stem Cell Transplantation for Patients with Hematologic Malignancies Using Campath-1H as Part of a Graft-versus-Host Disease Strategy

A Study of a Reduced-Intensity Conditioning Regimen Followed by Allogeneic Stem Cell Transplantation for Patients with Hematologic Malignancies Using Campath-1H as Part of a Graft-versus-Host Disease Strategy

by Shore, Tsiporah, Harpel, John, Schuster, Michael W., Roboz, Gail J., Leonard, John P., Coleman, Morton, Feldman, Eric J., Silver, Richard T.
Published in Biology of blood and marrow transplantation (01.08.2006)

Get full text

Journal Article

Inhibition of Tissue Plasminogen Activator Activity by Aspirin In Vivo and Its Relationship to Levels of Tissue Plasminogen Activator Antigen, Plasminogen Activator Inhibitor, and Their Complexes

Inhibition of Tissue Plasminogen Activator Activity by Aspirin In Vivo and Its Relationship to Levels of Tissue Plasminogen Activator Antigen, Plasminogen Activator Inhibitor, and Their Complexes

by Levin, Richard I., Harpel, Peter C., Harpel, John G., Recht, Phoebe A.
Published in Blood (01.10.1989)

Get full text

Journal Article

Control of transforming growth factor-β activity: Latency vs. activation

Control of transforming growth factor-β activity: Latency vs. activation

by Harpel, John G., Metz, Christine N., Kojima, Soichi, Rifkin, Daniel B.
Published in Progress in growth factor research (1992)

Get full text

Journal Article